Contact number
+1.617.948.6000Chambers Review
Latham & Watkins LLP is a strong team known for regularly representing global investment banks and issuers in the biotechnology and pharmaceutical spheres. Attorneys in the Boston office are experienced in dealing with IPOs and follow-on offerings.
Work Highlights
- Latham & Watkins LLP represented Amphenol in its offering of a $350 million aggregate principal amount of 4.75% senior unsecured notes due 2026.
Strengths
Provided by Chambers
"Latham & Watkins is a large firm that can handle a wide variety of issues with multidisciplinary teams."
"The firm has very solid specialists to address more nuanced matters."
"Latham & Watkins is a large firm that can handle a wide variety of issues with multidisciplinary teams."
"The firm has very solid specialists to address more nuanced matters."
Notable Practitioners
Peter Handrinos draws widespread praise for his extensive experience advising on IPOs and other high-value capital markets transactions. He counts global financial institutions and pharmaceutical companies among his clients.
"Peter knows the law backwards, he points out how to do things easily."
"Peter is the best there, he is on every front."
"He is deeply connected in the ecosystem."
Wesley Holmes comes recommended for his expertise in securities offerings.
"Wesley is a strong partner."
Jennifer Yoon is a partner in Latham's Boston office. Her practice focuses on capital markets transactions and securities matters, including share offerings, IPOs and follow-on offerings, often for clients in the life sciences sector.
"Jennifer is wonderful to work with, very professional and skilled."
"Jennifer is simply fantastic. She has the ability to juggle multiple complex workstreams and advise at both a granular and highly sophisticated level."